Streetbeat News

Regulatory

AMZN

INFA

Informatica (NYSE:INFA) announced new integrations with Amazon Web Services (AWS) at AWS re:Invent 2023, highlighting their growing collaboration. These integrations include support for Amazon Bedrock, a generative AI service, AWS HealthLake for healthcare data management, and Amazon S3 Access Grants for data lake permission management. The enhancements aim to provide trusted data for analytics and AI workloads, improve healthcare outcomes, and simplify data access with governance. Yamaha Motor Finance endorses the benefits of these integrations for data management and AI solutions.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 2:26 pm

EIS

A ceasefire between Israel and Hamas is holding, with ongoing hostage swaps. Israel has released 150 Palestinian detainees, while Hamas has freed 50 Israeli women and children. Negotiations are intensifying to extend the truce and secure the release of all remaining hostages. Diplomatic efforts include Mossad Chief David Barnea's discussions in Doha. Bernie Sanders criticized the US's unconditional support for Israel, and the WHO warned of a health crisis in Gaza. The shekel strengthened, and domestic stocks rose, with the iShares MSCI Israel ETF (EIS) reaching its highest level since early October.

Portfolio Pulse from Piero Cingari

November 28, 2023 | 2:26 pm

NVAX

Novavax Inc (NASDAQ:NVAX) stock is trading higher after the company's Covid-19 vaccine received Emergency Use Listing (EUL) from the World Health Organization (WHO) for individuals 12 years and older. The EUL facilitates expedited regulatory approvals for Novavax's vaccine in WHO's 194 member states. The vaccine's ease of transport and storage makes it suitable for rural or hard-to-reach areas, and it has shown to induce immune responses against multiple Covid variants.

Portfolio Pulse from Adam Eckert

November 28, 2023 | 2:08 pm

ADBE

AMZN

AVGO

IRBT

VMW

The UK's Competition and Markets Authority (CMA) has provisionally found that Adobe Inc's proposed $20 billion acquisition of Figma could reduce competition in the UK's digital design software market. Adobe and Figma disagree with the CMA's findings. The CMA will accept further comments until December 19 before making a final decision. Meanwhile, Broadcom Inc's merger with VMware, Inc has received all necessary approvals, and Amazon's acquisition of iRobot is expected to receive EU antitrust approval without conditions.

Portfolio Pulse from Anusuya Lahiri

November 28, 2023 | 1:54 pm

AIMD

Ainos, Inc. has announced the successful manufacturing of a GMP Clinical Batch of VELDONA by Swiss Pharmaceutical Co., Ltd. Ainos plans to submit IND applications to the U.S. FDA for multiple candidates, including treatments for HIV Oral Warts, Sjogren's Syndrome, the Common Cold, and COVID-19, in the first half of 2024. The company is preparing for Phase II and III studies and has highlighted the potential of VELDONA as an immune response booster and antiviral agent.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:41 pm

META

Meta Platforms, Inc. (META) is facing criticism for its new privacy fee strategy in Europe, where users can either agree to be tracked for personalized advertising or pay up to €251.88 annually for privacy on Instagram and Facebook. Advocacy group NOYB filed a complaint with the Austrian data protection authority, stating the cost is 'unacceptable' and could set a costly trend if other app providers follow suit. A Meta spokesperson defended the pricing, while META shares dropped slightly in premarket trading.

Portfolio Pulse from Nabaparna Bhattacharya

November 28, 2023 | 1:40 pm

EEIQ

EpicQuest Education Group International Limited (NASDAQ: EEIQ) announced the conversion of Davis College to Davis University, approved by regulatory authorities. This change is expected to enhance the institution's academic offerings, including new four-year degree programs in STEM and nursing, and bolster both domestic and international student recruitment. The company anticipates increased enrollment and revenue as a result of the university designation and expanded course offerings. Davis University currently has a significant increase in international students and is looking to strengthen collaborations with other institutions worldwide.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:35 pm

CDIO

The American Medical Association (AMA) is currently reviewing Cardio Diagnostics Holdings, Inc's integrated epigenetic-genetic tests for cardiovascular medicine to determine if they meet the criteria for Current Procedural Terminology (CPT) Proprietary Laboratory Analyses (PLA) codes. These codes are crucial for standardizing billing for lab tests and can significantly impact the reimbursement and adoption rates of new medical technologies.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:34 pm

BMRN

EWG

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has reached an agreement with the German National Association of Statutory Health Insurance Funds on the reimbursement for ROCTAVIAN, a gene therapy for severe hemophilia A. This marks the first gene therapy for hemophilia with an approved federal price in Germany. The therapy is priced at €28,933.53 per vial, approximately $900,000 per patient. The agreement includes an outcome-based model tied to real-world data and has a minimum term of 3 years. Two patients in Germany have received ROCTAVIAN, and 60 are eligible for treatment. BioMarin is also negotiating the final price with the Italian Medicines Agency and is working with U.S. payers to increase access to ROCTAVIAN.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:31 pm

EVAX

Evaxion Biotech has announced the successful design of precision cancer vaccines for hematological cancers using its AI-Immunology platform. The vaccines target a new class of antigens and have broad applicability for treating hematological malignancies, promising significant benefits for patients.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 1:28 pm